AstraZeneca begins global withdrawal of COVID-19 vaccine following decline in demand
The company applied to voluntarily withdraw its European marketing authorisation on 5 March
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Novo Nordisk Foundation, Wellcome and Gates Foundation collaborate to accelerate global health equity
The collaboration will support solutions to address the health impacts of climate change, infectious diseases and AMR
Novartis and PeptiDream expand peptide discovery collaboration in deal worth over $2.8bn
The agreement builds on the companies’ peptide-drug conjugate collaboration announced in 2019
AstraZeneca begins global withdrawal of COVID-19 vaccine following decline in demand
The company applied to voluntarily withdraw its European marketing authorisation on 5 March
AstraZeneca begins global withdrawal of COVID-19 vaccine following decline in demand
The company applied to voluntarily withdraw its European marketing authorisation on 5 March
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Latest content
Gilead Sciences appoints Peter Wickersham to vice-president and general manager in the UK and Ireland
Wickersham recently led Gilead’s liver disease and COVID-19 business unit in the US
Read More
Havas Life Medicom and Sciterion appoint Dick Dunford as group creative director
Dunford recently served as executive creative director at TBWA\WorldHealth
Read More
Intelligence
Achieving patient-guided drug development: putting the patient experience first
Why understanding all aspects of the patient journey is imperative to successful clinical research
Read More
Data integration and the AI healthcare revolution
Looking at some of the chief opportunities and challenges for digital health providers in implementing and scaling technological solutions in the UK
Read More
Is the gut microbiome the next frontier in medicine?
Research has long shown a strong connection between disease and the gut microbiome
Read More
Current trends and the renaissance of Alzheimer’s drug development
With 14 million people in Europe expected to suffer from Alzheimer’s and other forms of dementia by 2030, the race is on to find a treatment to not only slow its course, but even prevent the development of the disease
Read More
Rare diseases – raising awareness, listening to patients, making a difference
PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients with rare diseases and the barriers that are hindering access
Read More
Behavioural science – the route to healthcare salvation?
Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates
Read More
Blogs
Latest
NHS primary care panel – the GP Contract and Operational Planning Guidance – Live Webinar
May 7, 2024 | Mtech Access|GP contract, Market Access, NHS, NHS Whispers, Operational Planning Guidance, primary care
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract …
Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success
May 3, 2024 | Innovative Trials|Patient Retention, clinical trials, patient engagement, patient recruitment, pharmaceutical industry
Join this live webinar focusing on patient recruitment and retention in rare disease trials.
TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH
May 2, 2024 | Medscape Education Global|
It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data …
Hope in cancer therapy
May 1, 2024 | Springer Nature|Cancer therapy, biopharma dealmakers, biopharma investment, biopharma partner, dealmaking, radiopharmaceuticals
The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.
Health awareness days in May
May 1, 2024 | Springer Nature|Healthcare Advertising, clinicial advertising, health awareness days, medical marketing, physician marketing
Are you marketing to clinical audiences around upcoming health awareness days?
Beyond the AI anxiety: The impact of human intuition
May 7, 2024 | Mednet Group|AI, Innovation, Project Management, artificial intelligence, thought leadership
Explore the ways we’re adapting to work with AI, not against it
Navigating the rapidly changing oncology treatment landscape: how digital tools can help
May 2, 2024 | Impetus Digital|Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
The role of economic evaluation in US healthcare
April 30, 2024 | Mtech Access|AMCP, Health Economics, ICER, US healthcare, USA, health economic evaluation
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight …
Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot
April 24, 2024 | Research Partnership|Syndicated, market research, oncology, therapy watch
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a …
Navigating the future of AI: Insights from EphMRA’s one day meeting in London
April 22, 2024 | Research Partnership|
Authored by: Ellie Forde and Mark Braund, Directors